4th Edition of the TOR de France
Convention
From 09 to 10 October 2025
Target Of Rapamycin (TOR) pathway has an evolutionary conserved role in the control of growth, metabolism, stress response, survival and ageing.
Currently "TOR de France" is a unique conference series in the world entirely devoted to field of "Target Of Rapamycin" signaling, nutrition, growth, metabolism, development. The "TOR de France" meeting gathers students, postdocs, research group leaders and medical doctors working on various aspects of TOR biology and the applications in medicine, pharmacology, human health. This pluridiplinary approach allows new and fruitful feedbacks on everyone's work and have proven to foster innovative collaborations.